의료기기 이야기

We all know the chicken or the egg causality dilemma, often introduced as “what came first, the chicken or the egg?” You could pose a similar question for risk control measures referenced in HF validation tests: What comes first, the verification of use-related risk control measures or the HF validation test?   When to Verify Risk Control Measures | Emergo by UL When to Verify Risk Control Measu..

We present our insights from the past quarter. Advances in regulatory harmonization, as shared after the first three months and second three months of the year, continue. While it may have been a summer break for many, regulatory developments abound. This update features regulatory harmonization and a number of global developments revolving around Unique Device Identifiers (UDI). Word of the day..

Emergo by UL presented some of the elements to consider as part of the regulatory strategy: market and sales potential, reimbursement possibilities, academic and physician interest, and the regulatory system, including global harmonization or reliance. We use the example of South Korea where because of the public healthcare system (95% universal public healthcare system, 1989 National Health Ins..

BackgroundIn China, a series of State Orders have been promulgated to establish the legislative basis for medical device requirements. The current State Order is State Council Order No. 739, Regulations for the Supervision and Administration of Medical Devices.The NMPA has published a draft Medical Device Management Law (Aug. 28,) for public comment.  Proposed Medical Device Legislative Changes ..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Open Forum: Human Factors Usability Testing Q&A▶ 일시: 2024년 08월 22일 CST 9시 (한국시간: 08월 22일 23시)  Usability testing is one of the most important activities you can perform during the development of your medical device. Usability testing results can help you determine user needs, better understand use-related risks, inform your design process, and demonstrate safer a..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Japan Regulatory Requirements - Medical Device Software▶ 일시: 2024년 08월 08일 CST 9시 (한국시간: 08월 08일 23시) As the global market for medical device software (SaMD) expands, navigating the regulatory landscape becomes increasingly critical for manufacturers. While many regions share similar regulatory approaches, Japan presents unique challenges and opportunities. Our u..

Global harmonization continues to excite us all. And, global harmonization of medical device registration submissions is one way to advance the objectives of the International Medical Device Regulators Forum (IMDRF) and regulatory reliance. These documents are a must-read for any serious regulatory professional. Here we elaborate on our regulatory update featured in April 2023.  Background on IM..

Brazilian medical device regulator ANVISA has published new legislation allowing manufacturers of higher-risk devices to leverage registrations from some foreign regulatory authorities when applying for market access in Brazil. According to the new Reliance route which started June 3, ANVISA will now rely on the decisions of authorities from other jurisdictions, but remains independent and respo..

This is the second in our series of regulatory updates on the EU AI Act. We discussed AIA in our first regulatory update, the EU Artificial Intelligence Act. The EU AIA introduces a comprehensive framework for AI-enabled device regulation in the EU. In this regulatory update we discuss key elements of the regulation and best practices, enforcement and oversight, AI regulatory sandboxes and real-..

We at Emergo by UL are proud to have had one of our senior consultants attend the MedCon Conference in Columbus, Ohio on April 24-26. Here we describe some of our top pre-market consideration takeaways from the conference for those who were unable to make it. We encourage all regulatory professionals to consider attending next year! But if you can’t, no worries. We will report all the medical de..